Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys

  • Sylvain Baize
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Philippe Marianneau
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Philippe Loth
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Stéphanie Reynard
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Alexandra Journeaux
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Michèle Chevallier
    Biomnis, Lyon, France
  • Noël Tordo
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Vincent Deubel
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France
  • Hugues Contamin
    Unité de Biologie des Infections Virales Emergentes, Institut Pasteur-IFR 128 BioSciences Gerland—Lyon Sud, Lyon, France

説明

<jats:title>ABSTRACT</jats:title> <jats:p> Lassa virus causes a hemorrhagic fever endemic in West Africa. The pathogenesis and the immune responses associated with the disease are poorly understood, and no vaccine is available. We followed virological, pathological, and immunological markers associated with fatal and nonfatal Lassa virus infection of cynomolgus monkeys. The clinical picture was characterized by fever, weight loss, depression, and acute respiratory syndrome. Transient thrombocytopenia and lymphopenia, lymphadenopathy, splenomegaly, infiltration of mononuclear cells, and alterations of the liver, lungs, and endothelia were observed. Survivors exhibited fewer lesions and a lower viral load than nonsurvivors. Although all animals developed strong humoral responses, antibodies appeared more rapidly in survivors and were directed against GP <jats:sub>1</jats:sub> , GP <jats:sub>2</jats:sub> , and NP. Type I interferons were detected early after infection in survivors but only during the terminal stages in fatalities. The mRNAs for CXCL10 (IP-10) and CXCL11 (I-TAC) were abundant in peripheral blood mononuclear cells and lymph nodes from infected animals, but plasma interleukin-6 was detected only in fatalities. In survivors, high activated-monocyte counts were followed by a rise in the total number of circulating monocytes. Activated T lymphocytes circulated in survivors, whereas T-cell activation was low and delayed in fatalities. In vitro stimulation with inactivated Lassa virus induced activation of T lymphocytes from all infected monkeys, but only lymphocytes from survivors proliferated. Thus, early and strong immune responses and control of viral replication were associated with recovery, whereas fatal infection was characterized by major alterations of the blood formula and, in organs, weak immune responses and uncontrolled viral replication. </jats:p>

収録刊行物

  • Journal of Virology

    Journal of Virology 83 (11), 5890-5903, 2009-06

    American Society for Microbiology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ